User profiles for Oumar Sy

Oumar Sy

Associate Professor
Verified email at dal.ca
Cited by 378

Prevention of the epidemic increase in child risk of overweight in low-income schools: the El Paso coordinated approach to child health

…, CL Tiller, J Sanchez, EM Heath, O Sy… - … of pediatrics & …, 2005 - jamanetwork.com
Objective To assess the impact on children’s health of translating an evidence-based national
intervention trial (Child and Adolescent Trial for Cardiovascular Health [CATCH]) to low-…

Critical analysis of the performance of double-contrast barium enema for detecting colorectal polyps≥ 6 mm in the era of CT colonography

J Sosna, T Sella, O Sy, PT Lavin… - American Journal of …, 2008 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of our study was to perform a meta-analysis comparing the
performance of double-contrast barium enema (DCBE) with CT colonography (CTC) for the …

Dasatinib as a single agent in triple-negative breast cancer: results of an open-label phase 2 study

…, H Roché, J Sparano, LC Strauss, J Fairchild, O Sy… - Clinical Cancer …, 2011 - AACR
Purpose: Dasatinib is a potent, oral SRC-family kinase inhibitor with preclinical antiproliferative,
antimetastatic, and antiosteoclastic activity suggesting dasatinib sensitivity in triple-…

Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT‐2 follow‐up and post‐hoc analyses on progression‐free …

…, E Bleickardt, V Poulart, J Sheng, O Sy… - British journal of …, 2017 - Wiley Online Library
The randomized phase III ELOQUENT ‐2 study ( NCT 01239797) evaluated the efficacy
and safety of elotuzumab + lenalidomide/dexamethasone ( EL d) versus lenalidomide/…

Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended 4‐year follow‐up and analysis of relative progression‐free …

…, JE Signorovitch, D Makenbaeva, S Mekan, O Sy… - Cancer, 2018 - Wiley Online Library
Background The randomized phase 3 ELOQUENT‐2 study (NCT01239797) evaluated the
efficacy and safety of elotuzumab plus lenalidomide and dexamethasone (ELd) versus …

Phase 1 pharmacokinetic and drug‐interaction study of dasatinib in patients with advanced solid tumors

…, A Blackwood‐Chirchir, FR Luo, O Sy… - … Journal of the …, 2010 - Wiley Online Library
BACKGROUND: The recently developed the Src and Abelson (Abl) kinase inhibitor
dasatinib has antitumor effects in epithelial and mesenchymal tumors. Preclinical data have …

Dasatinib discontinuation in patients with chronic-phase chronic myeloid leukemia and stable deep molecular response: the DASFREE study

…, F Pane, FE Nicolini, MJ Mauro, O Sy… - Leukemia & …, 2020 - Taylor & Francis
Abstract Treatment-free remission (TFR) in patients with chronic myeloid leukemia in chronic
phase (CML-CP) is considered a feasible option, especially with the ability of second-…

A Phase 2 Trial of Dasatinib in Patients with Advanced HER2-Positive and/or Hormone Receptor–Positive Breast Cancer

…, M Campone, P Fumoleau, H Rugo, A Awada, O Sy… - Clinical cancer …, 2011 - AACR
Purpose: SRC-family kinases (SFK) are involved in numerous oncogenic signaling pathways.
A phase 2 trial of dasatinib, a potent oral tyrosine kinase inhibitor of SFKs, was carried out …

Resolving the presidential puzzle

O Sy, A Al Zaman - Financial Management, 2011 - Wiley Online Library
Many financial economists are puzzled by the fact that stock returns are higher under
Democratic than Republican presidencies. In this paper, we test whether this return differential is …

[HTML][HTML] Event studies in international finance research

S El Ghoul, O Guedhami, SA Mansi, O Sy - Journal of International …, 2023 - Springer
Event studies are widely used in finance research to investigate the implications of
announcements of corporate initiatives, regulatory changes, or macroeconomic shocks on stock …